Resmed RSMDF
NYSE RSMDF
$22.61 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Resmed (RSMDF) Non-Current Debt (2011 - 2026)

Resmed's (RSMDF) quarterly Non-Current Debt came in at $399.4 million in Q2 2026, down 39.33% on a YoY basis from $658.4 million in Q2 2025, and down 1.18% quarter-over-quarter from $404.2 million in Q1 2026.

Analysis

Resmed (RSMDF) Non-Current Debt (2011 - 2026) Analysis & Trends

Resmed (RSMDF) has reported Non-Current Debt for 16 consecutive years, with $399.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Debt fell 39.33% year-over-year to $399.4 million; the trailing twelve-month figure through Jun 2026 stood at $399.4 million (down 39.33% YoY), and the FY2026 full-year result was $399.4 million, down 39.33% from the prior year.
  • Non-Current Debt retreated to $399.4 million in Q2 2026 per RSMDF's latest filing, from $404.2 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.8 billion in Q4 2022 and bottomed at $399.4 million in Q2 2026.
  • Historically, Non-Current Debt has averaged $863.8 million across 5 years, with a median of $683.0 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Debt jumped 168.08% in 2022, then tumbled 51.28% in 2024.
  • Over 5 years, Non-Current Debt stood at $1.8 billion in 2022, then slumped by 32.05% to $1.2 billion in 2023, then sank by 45.52% to $662.9 million in 2024, then plunged by 39.06% to $403.9 million in 2025, then fell by 1.12% to $399.4 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $399.4 million, $404.2 million, and $403.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 183.94 Bn 178.34 Bn 7.27 Bn 29.60 Bn
2 Intuitive Surgical 124.29 Bn 119.08 Bn 1.96 Bn -
3 Medtronic 118.22 Bn 109.40 Bn 6.34 Bn 25.62 Bn
4 Stryker 104.52 Bn 101.04 Bn 4.50 Bn 14.19 Bn
5 Boston Scientific 66.33 Bn 65.79 Bn 3.85 Bn 10.92 Bn
6 Edwards Lifesciences 49.61 Bn 45.35 Bn 1.35 Bn 598.70 Mn
7 Alcon 33.94 Bn 32.49 Bn 1.68 Bn -1.00 Mn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn -
9 Steris 21.13 Bn 20.65 Bn 684.20 Mn 1.65 Bn
10 Resmed 3.54 Bn 2.07 Bn 861.22 Mn 399.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 399.42 Mn
Mar 31, 2026 404.17 Mn
Dec 31, 2025 403.92 Mn
Sep 30, 2025 408.66 Mn
Jun 30, 2025 658.39 Mn
Mar 31, 2025 663.13 Mn
Dec 31, 2024 662.86 Mn
Sep 30, 2024 667.58 Mn
Jun 30, 2024 697.31 Mn
Mar 31, 2024 997.05 Mn
Dec 31, 2023 1.22 Bn
Sep 30, 2023 1.35 Bn
Jun 30, 2023 1.43 Bn
Mar 31, 2023 1.58 Bn
Dec 31, 2022 1.79 Bn
Sep 30, 2022 785.44 Mn
Jun 30, 2022 765.33 Mn
Mar 31, 2022 668.74 Mn
Dec 31, 2021 667.98 Mn
Sep 30, 2021 793.67 Mn